rpn-3 Antibody

Shipped with Ice Packs
In Stock

Description

Rpn-3 in Proteasome Function and Cellular Regulation

Rpn-3 is essential for proteasome assembly and substrate recognition. Studies in Saccharomyces cerevisiae reveal that rpn3 mutants exhibit defective proteasome activity, leading to accumulation of polyubiquitinated proteins, cell cycle arrest at metaphase, and sensitivity to proteotoxic stressors . Key findings include:

  • Proteasome Stability: Rpn-3 ensures structural integrity of the 19S regulatory particle. Mutations (rpn3-4, rpn3-7) disrupt 19S-20S complex formation, impairing degradation of cell cycle regulators like Clb2 and Pds1 .

  • Ubiquitin-Dependent Proteolysis: Rpn-3 facilitates recognition of polyubiquitinated substrates. rpn3 mutants accumulate ubiquitinated proteins, highlighting its role in substrate shuttling .

  • Mitochondrial and Metabolic Roles: Rpn-3 deficiency correlates with mitochondrial dysfunction and altered glucose metabolism .

Applications of Rpn-3 Antibodies in Research

Commercial Rpn-3 antibodies enable species-specific detection and functional studies. Examples include:

Mechanistic Insights from Rpn-3 Antibody Studies

  • Cell Cycle Regulation: Anti-Rpn-3 antibodies identified metaphase arrest in rpn3 mutants due to stabilized cyclins (Clb2) and checkpoint inhibitors (Pds1) .

  • Immune Modulation: Rpn-3 interacts with ALG-2 in a Ca²⁺-dependent manner, linking proteasome activity to T cell apoptosis and immune response .

  • Disease Models: Rpn-3 dysfunction correlates with neurodegenerative and autoimmune pathologies, validated using epitope-specific antibodies .

Validation and Technical Considerations

  • Specificity: Antibodies against Schizosaccharomyces pombe Rpn-3 show no cross-reactivity with human PSMD3 .

  • Caution in Interpretation: Epitope accessibility varies between species; murine monoclonal antibodies may miss conformational epitopes in human cells .

Future Directions

  • Therapeutic Targeting: Rpn-3 antibodies could screen for proteasome inhibitors in cancer therapy.

  • Structural Studies: Cryo-EM with Rpn-3 antibodies may resolve 19S regulatory particle dynamics .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
rpn-3 antibody; C30C11.2 antibody; 26S proteasome non-ATPase regulatory subunit 3 antibody; 26S proteasome regulatory subunit rpn-3 antibody
Target Names
rpn-3
Uniprot No.

Target Background

Function
The antibody targets Rpn3, a regulatory subunit of the 26S proteasome. Rpn3 plays a critical role in the ATP-dependent degradation of ubiquitinated proteins.
Database Links

KEGG: cel:CELE_C30C11.2

STRING: 6239.C30C11.2.1

UniGene: Cel.5638

Protein Families
Proteasome subunit S3 family

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.